Cover Image
市場調查報告書

數位病理學的全球市場預測 2022年:掃描機、軟體、通信系統

Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 251934
出版日期 內容資訊 英文 156 Pages
訂單完成後即時交付
價格
Back to Top
數位病理學的全球市場預測 2022年:掃描機、軟體、通信系統 Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022
出版日期: 2017年10月16日 內容資訊: 英文 156 Pages
簡介

全球數位病理學市場規模,預計從2017到2022年以12.3%的年複合成長率發展,從2016年的3億8,390萬美元到2022年達到7億5,610萬美元。該市場的成長背景,有藥物研發及搭配診斷的數位病理學適用的增加,協商容易,提高研究所效率的數位病理學適用的增加,癌症的盛行率增加,政府及企業的配合措施的增加等。

本報告以全球數位病理學市場為研究主題,提供市場概要、趨勢概要,各類型、終端用戶、應用、地區的市場分析、預測,競爭情形分析,及主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 數位病理學市場概要
  • 歐洲市場佔有率:各應用/各國
  • 全球市場:各類型、各國
  • 數位病理學市場地區概要

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 促進要素
    • 阻礙要素
    • 機會
  • 法律規範

第6章 數位病理學市場:各產品

  • 簡介
  • 掃描機
  • 軟體
  • 通信系統
  • 存儲系統

第7章 數位病理學市場:各類型

  • 簡介
  • 人體數位病理學
  • 動物數位病理學

第8章 數位病理學市場:各應用領域

  • 簡介
  • 遠程醫療諮詢
  • 病的診斷
  • 藥物研發
  • 訓練、教育

第9章 數位病理學市場:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 醫院及參考檢驗室
  • 學術、研究機關

第10章 全球數位病理學市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區(ROW)

第11章 企業簡介

  • Leica Biosystems
  • Ventana Medical Systems
  • HAMAMATSU PHOTONICS
  • 3DHISTECH
  • Koninklijke Philips
  • Apollo Enterprise Imaging
  • XIFIN
  • Huron Digital Pathology
  • Visiopharm
  • Corista
  • Indica Labs
  • Objective Pathology Services

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HIT 2608

"The digital pathology market is projected to grow at a CAGR of 12.3%."

The global digital pathology market is expected to grow at a CAGR of 12.3% to reach to USD 756.1 million by 2022. Growth in the digital pathology market is mainly driven by factors such as the rising prevalence of cancer, growing applications of digital pathology in drug development and companion diagnostics, ease of consultation, increasing adoption of digital pathology to enhance lab efficiency, and increasing initiatives by governments and industry players. However, the high cost of digital pathology systems is expected to restrict market growth to a certain extent. Lack of standard guidelines may also challenge market growth in the coming years.

"The software segment to account for the largest share of the market."

By product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment is estimated to account for the largest share of the global digital pathology market in 2017. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe.

"The pharmaceutical and biotechnology companies segment to hold the largest market share in 2017."

On the basis of end user, the digital pathology market is classified into pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the digital pathology market. Factors contributing to the large share and high growth rate of this segment include the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, and molecular assays.

"North America to dominate the digital pathology market and APAC projected to grow at the highest CAGR during the forecast period."

The North American region is expected to hold the largest share of the global digital pathology market in 2017. The large share of this region can be attributed to factors such as the rising prevalence of chronic diseases and increasing initiatives by industry players and governments in diagnostics. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the digital pathology market in this region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1: 56%, Tier 2: 35%, and Tier 3: 9%
  • By Designation - C-level: 27%, Director Level: 15%, Others: 58%
  • By Region - North America: 45%, Europe: 29%, Asia Pacific: 20%, RoW: 6%

Leica Biosystems (Germany), Ventana Medical Systems (US), Hamamatsu Photonics (Japan), 3DHISTECH (Hungary), and Philips (Netherlands) are the key players in the digital pathology market.

Research Coverage:

The report analyzes the digital pathology market and aims at estimating the market size and the future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global digital pathology market
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global digital pathology market
  • Market Development: Comprehensive information about the lucrative emerging markets by product, type, application, end user, and region
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global digital pathology market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVRED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY RESEARCH
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. DIGITAL PATHOLOGY: MARKET OVERVIEW
  • 4.2. EUROPEAN DIGITAL PATHOLOGY MARKET SHARE, BY APPLICATION AND COUNTRY (2017)
  • 4.3. DIGITAL PATHOLOGY MARKET, BY TYPE VS. COUNTRY 2017 VS. 2022
  • 4.4. GEOGRAPHIC SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing adoption of digital pathology to enhance lab efficiency
      • 5.2.1.2. Rising prevalence of cancer
      • 5.2.1.3. Growing applications of digital pathology in drug development and companion diagnostics
      • 5.2.1.4. Ease of consultation enabled by digital pathology
      • 5.2.1.5. Increasing initiatives by governments and industry players
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of digital pathology systems
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Overcoming the shortage of pathologists through digital pathology
      • 5.2.3.2. Introduction of affordable scanners for private pathology practices
      • 5.2.3.3. Personalized medicine
      • 5.2.3.4. Integration of laboratory information systems (LIS) and digital pathology systems
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Lack of standard guidelines
  • 5.3. REGULATORY IMPLICATIONS
    • 5.3.1. HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA)
    • 5.3.2. CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA)

6. DIGITAL PATHOLOGY MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SCANNERS
  • 6.3. SOFTWARE
  • 6.4. COMMUNICATION SYSTEMS
  • 6.5. STORAGE SYSTEMS

7. DIGITAL PATHOLOGY MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. HUMAN PATHOLOGY
  • 7.3. VETERINARY PATHOLOGY

8. DIGITAL PATHOLOGY MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. TELECONSULTATION
  • 8.3. DISEASE DIAGNOSIS
  • 8.4. DRUG DISCOVERY
  • 8.5. TRAINING AND EDUCATION

9. DIGITAL PATHOLOGY MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.3. HOSPITALS AND REFERENCE LABORATORIES
  • 9.4. ACADEMIC & RESEARCH INSTITUTES

10. GLOBAL DIGITAL PATHOLOGY MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
      • 10.2.1.1. Favorable reimbursement scenario for digital pathology in the US
      • 10.2.1.2. Rising cancer prevalence in the US
      • 10.2.1.3. De Novo application by the FDA
      • 10.2.1.4. Conferences and meetings in the US
    • 10.2.2. CANADA
      • 10.2.2.1. Growing need for quality cancer diagnosis in Canada
      • 10.2.2.2. Implementation of favorable initiatives by Canadian authorities
  • 10.3. EUROPE
    • 10.3.1. UK
      • 10.3.1.1. Initiatives adopted by NHS England promoting the adoption of digital pathology in the UK
      • 10.3.1.2. Technological developments in the UK market
      • 10.3.1.3. Organization of digital pathology-related conferences in the UK
    • 10.3.2. GERMANY
      • 10.3.2.1. Organization of digital pathology-related conferences in Germany
    • 10.3.3. SWEDEN
      • 10.3.3.1. Increasing government initiatives and deployment of digital pathology solutions
    • 10.3.4. DENMARK
      • 10.3.4.1. High cancer prevalence to boost market growth in Denmark
    • 10.3.5. REST OF EUROPE (ROE)
      • 10.3.5.1. Integration & deployment of digital pathology solutions in France
      • 10.3.5.2. Spain: implementation of digital pathology-related projects
      • 10.3.5.3. Digital pathology gaining momentum in the Netherlands
  • 10.4. ASIA PACIFIC
    • 10.4.1. CHINA
      • 10.4.1.1. Industry initiatives to boost digital pathology market in China
      • 10.4.1.2. Favorable initiatives for the adoption of telepathology in China
    • 10.4.2. JAPAN
      • 10.4.2.1. Initiatives by industry players for cancer diagnosis
    • 10.4.3. INDIA
      • 10.4.3.1. Increasing incidence of cancer in India
    • 10.4.4. REST OF ASIA PACIFIC
      • 10.4.4.1. Cancer control initiatives in Australia
  • 10.5. ROW
      • 10.5.1.1. Potential for the growth of digital pathology in Africa
      • 10.5.1.2. Increasing focus of industry players on the Middle East

11. COMPANY PROFILES (Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*

  • 11.1. LEICA BIOSYSTEMS
  • 11.2. VENTANA MEDICAL SYSTEMS
  • 11.3. HAMAMATSU PHOTONICS
  • 11.4. 3DHISTECH
  • 11.5. KONINKLIJKE PHILIPS
  • 11.6. APOLLO ENTERPRISE IMAGING
  • 11.7. XIFIN
  • 11.8. HURON DIGITAL PATHOLOGY
  • 11.9. VISIOPHARM
  • 11.10. CORISTA
  • 11.11. INDICA LABS
  • 11.12. OBJECTIVE PATHOLOGY SERVICES

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 2: DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 3: DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2015-2022 (UNITS)
  • TABLE 4: TYPES OF DIGITAL PATHOLOGY SOFTWARE
  • TABLE 5: DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 6: COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY
  • TABLE 7: DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 8: DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 9: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 10: HUMAN PATHOLOGY MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 11: VETERINARY PATHOLOGY MARKET, BY COUNTRY/ REGION, 2015-2022 (USD MILLION)
  • TABLE 12: GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 13: DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 14: DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 15: DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 16: DIGITAL PATHOLOGY MARKET FOR TRAINING AND EDUCATION, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 17: GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 18: DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: DIGITAL PATHOLOGY MARKET FOR HOSPITAL AND REFERENCE LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: DIGITAL PATHOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: DIGITAL PATHOLOGY MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 27: CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US
  • TABLE 28: US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 29: US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 30: US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 31: US: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 32: CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 33: CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 35: CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 37: EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 38: EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 40: EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 41: UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 42: UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 44: UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 45: GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 46: GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 50: SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 52: SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 53: DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 56: DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 57: ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 58: ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 60: ROE: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 65: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 66: CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 67: CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 69: CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 71: JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 72: JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 73: JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 74: INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 75: INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 77: INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 78: ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 79: ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 80: ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 81: ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 82: ROW: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 83: ROW: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: ROW: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 85: ROW: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION
  • FIGURE 2: GLOBAL DIGITAL PATHOLOGY MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: DIGITAL PATHOLOGY MARKET ANALYSIS, BY PRODUCT (2017)
  • FIGURE 7: DIGITAL PATHOLOGY MARKET ANALYSIS, BY TYPE, 2017 VS. 2022
  • FIGURE 8: DIGITAL PATHOLOGY MARKET ANALYSIS, BY APPLICATION (2017)
  • FIGURE 9: DIGITAL PATHOLOGY MARKET ANALYSIS, BY END USER, 2017 VS. 2022
  • FIGURE 10: ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: INCREASING ADOPTION OF DIGITAL PATHOLOGY IS A MAJOR FACTOR DRIVING THE GROWTH OF THE DIGITAL PATHOLOGY MARKET
  • FIGURE 12: TELECONSULTATION IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2017
  • FIGURE 13: HUMAN PATHOLOGY TO CONTINUE TO DOMINATE THE DIGITAL PATHOLOGY MARKET IN 2022
  • FIGURE 14: CHINA TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 15: DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: NUMBER OF NEW CANCER CASES, BY COUNTRY, 2012 VS. 2020
  • FIGURE 17: SCANNERS SEGMENT TO DOMINATE THE DIGITAL PATHOLOGY PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: DIGITAL PATHOLOGY MARKET, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 19: TELECONSULTATION COMMANDS FOR LARGEST MARKET SIZE OF THE DIGITAL PATHOLOGY MARKET IN 2017, BY APPLICATION
  • FIGURE 20: GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER, 2017-2022
  • FIGURE 21: DIGITAL PATHOLOGY MARKET, BY REGION, 2017
  • FIGURE 22: NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 23: INCREASING PREVALENCE OF CANCER - A MAJOR FACTOR DRIVING THE NORTH AMERICAN MARKET
  • FIGURE 24: EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 25: EUROPE: NUMBER OF CANCER CASES REPORTED, BY COUNTRY
  • FIGURE 26: CANCER PREVALENCE IN DENMARK
  • FIGURE 27: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 28: NUMBER OF NEW CANCER CASES, BY TYPE
  • FIGURE 29: ROW: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 30: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 31: ROCHE GROUP: COMPANY SNAPSHOT
  • FIGURE 32: HAMAMATSU PHOTONICS: COMPANY SNAPSHOT
  • FIGURE 33: KONINKLIJKE PHILIPS: COMPANY SNAPSHOT
Back to Top